POST Online Media Lite Edition



 

Pfizer: Olivier Brandicourt president and GM, Emerging Markets and Established Products

Staff writer |
New York, USA - May 23, 2012, New York, USA - Pfizer Inc. named Olivier Brandicourt as president and general manager of the Emerging Markets and Established Products Business Units, effective June 1, 2012.

Article continues below






Dr. Brandicourt has held senior positions at Pfizer across a range of disciplines, including medical and marketing, as well as country and regional management roles in Latin America, Europe, Canada, the United Kingdom and the United States.

Mr. Brandicourt has been the President and General Manager of Pfizer's worldwide primary care business at Pfizer Inc. since 2008. Mr. Brandicourt served as Senior Vice President and General Manager of U.S. Pratt Business Unit at Pfizer Inc. from 2007 to 2008. Mr. Brandicourt served as Managing Director of the United Kingdom/Ireland Pfizer subsidiary from 2004 to 2007. He is an Honorary Fellow of the Royal College of Physicians in London and a trustee of the Children’s Aid Society of New York.

Dr. Brandicourt holds a medical degree with a subspecialty in infectious diseases and Tropical Medicine, as well as a masters degree in biology from Paris University. After completing his studies, HE spent two years in the Congo as a doctor and eight years with the tropical disease Institute in Paris, where he spent half his time in West and Central Africa working on malaria research. Dr. Brandicourt is an Honorary Fellow of the Royal College of Physicians in London.

 LATEST MOVES FROM USA 

Ichnos Sciences appoints Sonia Quaratino to board
Ichnos Sciences welcomes Eric Feldman as new chief medical officer
Capital One Financial appoints Christine Detrick to board
Bankers Insurance hires David A. Erwin as president and CEO
American Equity Investment Life Holding appoints Dewayne Lummus as SVP

What to read next

Olivier Brandicourt new CEO of Bayer HealthCare
Pfizer: Jeffrey B. Kindler retires, Ian C. Read successor
SPAR Group appoints Christiaan M. Olivier to board